(IBIO) iBio Common Stock - Performance -58.9% in 12m
Compare IBIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-67.40%
#96 in Group
Rel. Strength
10.41%
#7129 in Universe
Total Return 12m
-58.87%
#112 in Group
Total Return 5y
-99.86%
#194 in Group
P/E 0.71
14th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: IBIO (-58.9%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: IBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IBIO
| Total Return (including Dividends) | IBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -39.59% | 2.02% | 2.87% |
| 3 Months | -77.39% | -15.44% | -6.42% |
| 12 Months | -58.87% | -14.02% | 9.87% |
| 5 Years | -99.86% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | IBIO | XBI | S&P 500 |
| 1 Month | -46.6% | 57% | 89.4% |
| 3 Months | -68.0% | -82.3% | -72% |
| 12 Months | 31.8% | -53.1% | 49.3% |
| 5 Years | -95.2% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #200 | -40.8% | -41.3% |
| 3 Month | #197 | -73.3% | -75.8% |
| 12 Month | #112 | -52.2% | -62.6% |
| 5 Years | #194 | -99.8% | -99.9% |
FAQs
Does IBIO iBio Common Stock outperforms the market?
No,
over the last 12 months IBIO made -58.87%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months IBIO made -77.39%, while XBI made -15.44%.
Over the last 3 months IBIO made -77.39%, while XBI made -15.44%.
Performance Comparison IBIO vs Indeces and Sectors
IBIO vs. Indices IBIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -23.0% | -42.5% | -64.6% | -68.7% |
| US NASDAQ 100 | QQQ | -23.3% | -44.3% | -65.1% | -70.2% |
| US Dow Jones Industrial 30 | DIA | -23.3% | -41.2% | -63.6% | -65.2% |
| German DAX 40 | DAX | -25.1% | -58.9% | -90.2% | -84.0% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -23.7% | -45.9% | -63.9% | -64.5% |
| Hongkong Hang Seng | HSI | -26.5% | -55.8% | -74.1% | -71.0% |
| India NIFTY 50 | INDA | -20.6% | -41.9% | -66.5% | -61.2% |
| Brasil Bovespa | EWZ | -25.1% | -51.1% | -73.9% | -52.4% |
IBIO vs. Sectors IBIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -23.2% | -43.3% | -70.8% | -79.2% |
| Consumer Discretionary | XLY | -23.9% | -43.1% | -62.5% | -72.9% |
| Consumer Staples | XLP | -22.6% | -41.6% | -71.6% | -66.4% |
| Energy | XLE | -24.0% | -39.7% | -58.6% | -49.1% |
| Financial | XLF | -23.6% | -45.2% | -70.5% | -80.4% |
| Health Care | XLV | -19.2% | -35.2% | -59.4% | -53.0% |
| Industrial | XLI | -24.6% | -47.0% | -65.6% | -68.9% |
| Materials | XLB | -23.0% | -44.3% | -60.6% | -52.8% |
| Real Estate | XLRE | -22.7% | -45.7% | -67.0% | -72.3% |
| Technology | XLK | -23.9% | -46.3% | -62.4% | -65.9% |
| Utilities | XLU | -24.1% | -45.2% | -72.4% | -74.8% |
| Aerospace & Defense | XAR | -23.5% | -48.9% | -73.9% | -84.0% |
| Biotech | XBI | -14.9% | -41.6% | -43.6% | -44.9% |
| Homebuilder | XHB | -22.6% | -42.7% | -51.0% | -49.1% |
| Retail | XRT | -23.2% | -43.2% | -58.4% | -54.6% |